Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01829971
Title A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirna Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Virginia G. Piper Cancer Center Scottsdale Arizona 85258 United States Details
Mayo Clinic Arizona Scottsdale Arizona 85259 United States Details
Texas Oncology Dallas Dallas Texas 75246 United States Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Uthscsa/Ctrc San Antonio Texas 78229 United States Details
Severance Hospital, Yonsie University Health System Seoul Seodaemun-Gu 03722 Korea, Republic of Details
Seoul National University Hospital Seoul 110-744 Korea, Republic of Details
Samsung Medical Center Seoul 135-710 Korea, Republic of Details
Asan Medical Center Seoul 138-736 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field